News

Saint Luke's Rehabilitation Institute's newest staff member is making an immediate impact on patient care this year. Henli is a two-year old facility dog, highly trained to work in clinical settings alongside licensed therapists.

Dana Boucher found relief with LUTATHERA, a targeted radioactive therapy specifically for neuroendocrine tumors (NETs) found in the gut or pancreas.

Two years after an intern presented on the clinical and emotional benefits of service animals, the Rehabilitation Institute is delighted to introduce the world to Henli, a highly trained dog with a knack for comfort and connection.

This MS awareness month, Dr. Carolina Garcia, a neurologist at Saint Luke's Comprehensive Multiple Sclerosis Center, discusses diagnosing and treating this inflammatory and presumed autoimmune condition.

Growing research shows why popular GLP-1 weight loss medications might be beneficial for people with multiple sclerosis, but the jury’s still out.

Empower yourself by learning all you can about therapies for multiple sclerosis.

FOX4 talked to Dr. Karin Olds about Guillain-Barre Syndrome and recovery.

A recent study out of Harvard School of Public Health found a strong relationship between those who had mononucleosis, or the “kissing disease,” and multiple sclerosis later in life.

An expert with Saint Luke’s Comprehensive Multiple Sclerosis Center discusses early detection and exciting new advances in treatment.